Back to Browse Journals » Therapeutics and Clinical Risk Management » Volume 5

The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability

Authors Megan N Beatty, Paul D Blumenthal

Published Date July 2009 Volume 2009:5 Pages 561—574

DOI http://dx.doi.org/10.2147/TCRM.S5624

Published 22 July 2009

Megan N Beatty, Paul D Blumenthal

Department of Obstetrics and Gynecology, Stanford University, Stanford, CA, USA

Abstract: The levonorgestrel-releasing intrauterine system (LNG-IUS) is a safe, effective and acceptable form of contraception used by over 150 million women worldwide. It also has a variety of noncontraceptive benefits including treatment for menorrhagia, endometriosis, and endometrial hyperplasia. The LNG-IUS has also been used in combination with estrogen for hormone replacement therapy and as an alternative to hysterectomy. Overall, the system is very well tolerated and patient satisfaction is quite high when proper education regarding possible side effects is provided. However, despite all of the obvious benefits of the LNG-IUS, utilization rates remain quite low in the developed countries, especially in the United States. This is thought to be largely secondary to the persistent negative impressions from the Dalkon Shield intrauterine experience in the 1970s. This history continues to negatively influence the opinions of both patients and health care providers with regards to intrauterine devices. Providers should resolve to educate themselves and their patients on the current indications and uses for this device, as it, and intrauterine contraception in general, remains a largely underutilized approach to a variety of women’s health issues.

Keywords: Mirena®, levonorgestrel-releasing, intrauterine system, intrauterine contraceptive device

General overview

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

The skin landscape in diabetes mellitus. Focus on dermocosmetic management

Piérard GE, Seité S, Hermanns-Lê T, Delvenne P, Scheen A, Piérard-Franchimont C

Clinical, Cosmetic and Investigational Dermatology 2013, 6:127-135

Published Date: 15 May 2013

Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study

Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad SN

International Journal of Nanomedicine 2012, 7:1851-1863

Published Date: 11 April 2012

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy

Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I

Neuropsychiatric Disease and Treatment 2012, 8:85-93

Published Date: 9 February 2012

Synthesis and characterization of electrospun polyvinyl alcohol nanofibrous scaffolds modified by blending with chitosan for neural tissue engineering

Naghavi Alhosseini S, Moztarzadeh F, Mozafari M, Asgari S, Dodel M, Samadikuchaksaraei A, Kargozar S, Jalali N

International Journal of Nanomedicine 2012, 7:25-34

Published Date: 4 January 2012

Influence of synthetic superparamagnetic iron oxide on dendritic cells

Mou Y, Chen B, Zhang Y, Hou Y, Xie H, Xia G, Tang M, Huang X, Ni Y, Hu Q

International Journal of Nanomedicine 2011, 6:1779-1786

Published Date: 25 August 2011

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009

Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes

Minoru Yamaoka, Yusuke Ono, Masahide Ishizuka, Kouichi Yasuda, et al.

Clinical, Cosmetic and Investigational Dentistry 2009, 1:27-34

Published Date: 11 May 2009